What is the POSCORAD?

POSCORAD is derived from the SCORAD, one of the most widely used assessment scores.

POSCORAD is a useful tool dedicated to patients suffering from eczema.

POSCORAD is a score, which can be easily used by the patient without any particular experience.

POSCORAD was created for the patient in order to help patients or caregivers to follow the course of the disease and the effect of the treatment.

POSCORAD has been validated in several studies (Vourc’h-Jourdain M, Barbarot S, Taieb A et al. Patient-oriented SCORAD: a self-assessment score in atopic dermatitis. A preliminary feasibility study. Dermatology. 2009;218:246-251.

Stalder JF, Barbarot S, Wollenberg A et al. Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe. Allergy. 2011;66:1114-1121.)

Please note: Our aim is to constantly improve the application so we would like the opinion of the users by filling in the questionnaire, accessible by clicking on the button on the top-left of the POSCORAD screen.

Why use the POSCORAD?

AD is a chronic disease and which is mainly treated using local treatments that the patients themselves apply.

The efficacy of the treatment is thus directly related to the patient’s observance.

Doctors frequently use assessment scores during their consultations to evaluate the extent and severity of the disease (SCORAD). In atopic patients the course of the disease can vary considerably between two visits and the profile of this fluctuation is essential in order to know the real impact of the treatment. POSCORAD can help the patients to calculate, by themselves, the severity of their disease.

Who owns the POSCORAD?

POSCORAD was created by a group of experts (ETFAD) in order to help doctors and patients to improve the management of atopic dermatitis.

How can I obtain the POSCORAD?

POSCORAD is available as a free download below.

This software contains an illustrated application for assessing severity, extent, pruritus and sleep loss. A regular (weekly) use of this application allows the patient to create a curve representing the fluctuations of his disease between consultations.

To date there are 2 electronic applications available: French and English. However, we have translated the content into 18 different languages*. These versions are available in paper from and can be used with the English or French electronic versions. To obtain a paper version of the POSCORAD in one of these languages, send your request to jfstalder@mac.com.

* English, French, German, Italian, Spanish, Japanese, Chinese (traditional or modern), Swedish, Danish, Norwegian, Finnish, Dutch, Flemish, Korean, Czech, Polish, Russian, Portugese.

How can I use the POSCORAD in clinical research?

POSCORAD was created in the aim of a large distribution. It has been translated into 14 languages.

-In clinical research the use of POSCORAD is subject to a formal demand for authorisation, which should be submitted to Prof. Jean François Stalder at this address: jfstalder@mac.com. 

-All academic researchers and non-profit groups can use the POSCORAD for free.

-All pharmaceutical companies should give a donation for using this tool (1500€ minimum). To make a donation you should contact the secretary of ANDRAC (Association Nantais de Recherche sur les maladies Cutanés) at this address: dermatodelouest@univ-nantes.fr.

1. -The donation fund will be used to enlarge the scope of the tool (translation, improvements etc.).
   

To obtain autorisation to use the POSCORAD, please download the following form and return it                  to jfstalder@mac.com